These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 17465999)

  • 1. Serum leptin, oxidized low density lipoprotein and plasma asymmetric dimethylarginine levels and their relationship with dyslipidaemia in adolescent girls with polycystic ovary syndrome.
    Demirel F; Bideci A; Cinaz P; Camurdan MO; Biberoğlu G; Yesilkaya E; Hasanoğlu A
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):129-34. PubMed ID: 17465999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum retinol-binding protein 4, leptin, and plasma asymmetric dimethylarginine levels in obese and nonobese young women with polycystic ovary syndrome.
    Yildizhan R; Ilhan GA; Yildizhan B; Kolusari A; Adali E; Bugdayci G
    Fertil Steril; 2011 Jul; 96(1):246-50. PubMed ID: 21600576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome.
    Berneis K; Rizzo M; Hersberger M; Rini GB; Di Fede G; Pepe I; Spinas GA; Carmina E
    Int J Clin Pract; 2009 Jan; 63(1):56-62. PubMed ID: 19125993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
    Holte J; Bergh T; Berne C; Lithell H
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study.
    Valkenburg O; Steegers-Theunissen RP; Smedts HP; Dallinga-Thie GM; Fauser BC; Westerveld EH; Laven JS
    J Clin Endocrinol Metab; 2008 Feb; 93(2):470-6. PubMed ID: 18056772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
    Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
    Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atherogenic changes in low-density lipoprotein particle profiles were not observed in non-obese women with polycystic ovary syndrome.
    Kim JJ; Chae SJ; Choi YM; Hwang KR; Song SH; Yoon SH; Kim SM; Ku SY; Kim SH; Kim JG; Moon SY
    Hum Reprod; 2013 May; 28(5):1354-60. PubMed ID: 23477907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of obesity on atherogenic dyslipidemia in women with polycystic ovary syndrome.
    Hernández-Mijares A; Bañuls C; Gómez-Balaguer M; Bergoglio M; Víctor VM; Rocha M
    Eur J Clin Invest; 2013 Jun; 43(6):549-56. PubMed ID: 23528141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptin levels in women with polycystic ovaries undergoing ovarian stimulation: relation to lipoprotein profiles.
    Tsouma I; Kouskouni E; Gennimata V; Demeridou S; Boutsikou M; Grigoriou V; Chasiakou A; Hassiakou S; Baka S
    In Vivo; 2014; 28(5):989-92. PubMed ID: 25189919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetric dimethylarginine levels and carotid intima-media thickness in obese patients with polycystic ovary syndrome and their relationship to metabolic parameters.
    Pamuk BO; Torun AN; Kulaksizoglu M; Ertugrul D; Ciftci O; Kulaksizoglu S; Yildirim E; Demirag NG
    Fertil Steril; 2010 Mar; 93(4):1227-33. PubMed ID: 19108830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic effect of obesity on polycystic ovary syndrome in adolescents: a meta-analysis.
    Li L; Feng Q; Ye M; He Y; Yao A; Shi K
    J Obstet Gynaecol; 2017 Nov; 37(8):1036-1047. PubMed ID: 28657375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome.
    Berneis K; Rizzo M; Lazzarini V; Fruzzetti F; Carmina E
    J Clin Endocrinol Metab; 2007 Jan; 92(1):186-9. PubMed ID: 17062762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smaller LDL particle size in women with polycystic ovary syndrome compared to controls.
    Dejager S; Pichard C; Giral P; Bruckert E; Federspield MC; Beucler I; Turpin G
    Clin Endocrinol (Oxf); 2001 Apr; 54(4):455-62. PubMed ID: 11318780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters.
    Pirwany IR; Fleming R; Greer IA; Packard CJ; Sattar N
    Clin Endocrinol (Oxf); 2001 Apr; 54(4):447-53. PubMed ID: 11318779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered composition of high density lipoproteins in women with the polycystic ovary syndrome.
    Rajkhowa M; Neary RH; Kumpatla P; Game FL; Jones PW; Obhrai MS; Clayton RN
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3389-94. PubMed ID: 9329374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Monocyte chemoattractant protein-1 and its correlation with lipoprotein in polycystic ovary syndrome].
    Hu WH; Qiao J; Zhao SY; Zhang XW; Li MZ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):487-91. PubMed ID: 17068620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is serum leptin level regulated by thyroid functions, lipid metabolism and insulin resistance in polycystic ovary syndrome?
    Erel CT; Senturk LM; Kaleli S; Gezer A; Baysal B; Tasan E
    Gynecol Endocrinol; 2003 Jun; 17(3):223-9. PubMed ID: 12857430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased cholesterol efflux capacity and atherogenic lipid profile in young women with PCOS.
    Roe A; Hillman J; Butts S; Smith M; Rader D; Playford M; Mehta NN; Dokras A
    J Clin Endocrinol Metab; 2014 May; 99(5):E841-7. PubMed ID: 24512495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression of lipoprotein(a) and oxidized low-density lipoprotein, lipid profiles and biomarkers of oxidative stress in patients with polycystic ovary syndrome.
    Rahmani E; Samimi M; Ebrahimi FA; Foroozanfard F; Ahmadi S; Rahimi M; Jamilian M; Aghadavod E; Bahmani F; Taghizadeh M; Memarzadeh MR; Asemi Z
    Mol Cell Endocrinol; 2017 Jan; 439():247-255. PubMed ID: 27619403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.